Table 4 Main outcomes and test results of new 15 patients with LTBI before and after treatment with isoniazid
Patient | Dx | TNF blocker | LT (years) | EPI | BCG | TST | Booster | ELISPOT | QFT | TST after | ELISPOT after | QFT after treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | AS | ETA | 3 | − | + | 10 | NA | + | − | 15 | − | − |
2 | PsA | IFX | 4 | − | − | 8 | NA | + | + | 7 | + | + |
3 | AS | ETA | 1 | − | + | 0 | 3 | + | + | 0 | + | − |
4* | AS | IFX | 3 | − | + | 10 | NA | + | + | 0 | + | + |
5 | AS | ADA | 5 | − | − | 10 | NA | + | − | 10 | Indet | − |
6 | RA | IFX | 1 | − | − | 5 | NA | + | + | 20 | + | + |
7 | RA | ETA | 2 | − | − | 0 | 0 | + | + | 4 | − | + |
8 | RA | ETA | 1 | + | + | 16 | NA | − | − | 15 | − | − |
9 | RA | IFX | 2 | − | + | 9 | NA | + | − | 8 | + | + |
10 | RA | ETA | 3 | − | + | 15 | NA | − | − | 0 | − | + |
11 | JIA | ETA | 2 | − | + | 0 | 0 | + | + | 0 | + | + |
12 | PsA | IFX | 3 | − | − | 10 | NA | − | − | 8 | Indet | − |
13 | AS | ADA | 2 | − | − | 5 | NA | − | − | 5 | − | − |
14 | RA | ETA | 3 | − | + | 0 | 0 | + | − | 0 | + | + |
15 | RA | ETA | 1 | + | + | 4 | 10 | + | + | 4 | + | + |